Skip to main content
Clinical Trials/NCT03229460
NCT03229460UnknownNot Applicable

High Flow Nasal Oxygen Therapy in Perioperative Period of the Adult With Hypercapnic and Hypoxemic Respiratory Faliure

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine1 site in 1 country150 target enrollmentStarted: August 1, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
150
Locations
1
Primary Endpoint
the number of patients in each group who require endotracheal intubation with mechanical ventilation

Study Overview

Brief Summary

The purpose of this study is to determine the impact of hign-flow nasal therapy on the adult with hypercapnia and hpoxemia respiratory faliure in comparison with standard oxygen therapy ang noninvasive ventilation.

Detailed Description

Humidified high flow nasal oxygen therapy decreases dilution of the inhaled oxygen and, by matching patient's peak flow, allows accurate delivery of the set FiO2 throughout the whole inspiratory phase.The purpose of this study is to determine the impact of hign-flow nasal therapy on adult hypercapnic respiratory failure by comparing with nasal continuous positive airway pressure

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Hypoxemic and no hypercapnic acute respiratory failure :
  • •severe dyspnea at rest with a respiratory rate >25 breaths/min
  • •PaO2/FiO2 <300
  • •PaCO2 <45 mmHg,

Exclusion Criteria

  • •age <18 years
  • •NPPV contraindications
  • •past history of respiratory chronic disease (COPD, cystic fibrosis...)
  • •cardiac pulmonary edema
  • •Pre-defined intubation
  • •other than respiratory organ failure : systolic pressure <90 mmHg,current treatment with epinephrine or norepinephrine, decreased level of consciousness ( Glasgow score ≤ 12)
  • •profound aplasia (white cells count <1000/mm 3)

Arms & Interventions

standard low flow therapy

Active Comparator

In the standard low flow therapy is applied continuously through a nonrebreather face mask at a flow rate of 10 liters per minute or more. The rate was adjusted to maintain an oxygen saturation level of 92% or more.

Intervention: standard low flow therapy (Other)

high flow nasal oxygen therapy

Experimental

In the high-flow-oxygen group is passed through a heated humidifier and applied continuously through large-bore binasal prongs, with a gas flow rate of 30-60 liters per minute . The fraction of oxygen in the gas flowing in the system was subsequently adjusted to maintain an Spo2 of 92% or more.

Intervention: high flow nasal oxygen therapy (Device)

Noninvasive ventilation

Placebo Comparator

In the noninvasive-ventilation group is delivered to the patient through a face mask that was connected to an ICU ventilator,with pressure support applied in a noninvasive ventilation mode. The Fio2 or PEEP level (or both) were then adjusted to maintain an Spo2 of 92% or more.

Intervention: association of high flow nasal oxygen therapy and non invasive positive pressure ventilation (Device)

Outcomes

Primary Outcomes

the number of patients in each group who require endotracheal intubation with mechanical ventilation

Time Frame: 28days

To compare the number of patients in each group who require endotracheal intubation with mechanical ventilation

Secondary Outcomes

  • mechanical ventilation-free to day 28(28 days)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Bin He

M.D./Ph.D.

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Study Sites (1)

Loading locations...

Similar Trials